PT1061901E - Inalador de nicotina - Google Patents

Inalador de nicotina

Info

Publication number
PT1061901E
PT1061901E PT99939159T PT99939159T PT1061901E PT 1061901 E PT1061901 E PT 1061901E PT 99939159 T PT99939159 T PT 99939159T PT 99939159 T PT99939159 T PT 99939159T PT 1061901 E PT1061901 E PT 1061901E
Authority
PT
Portugal
Prior art keywords
nicotine
medicament
flowable mixture
produce
nicotine inhaler
Prior art date
Application number
PT99939159T
Other languages
English (en)
Inventor
Piskorz Hanna
Original Assignee
Nico Puff Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nico Puff Corp filed Critical Nico Puff Corp
Publication of PT1061901E publication Critical patent/PT1061901E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT99939159T 1998-03-11 1999-03-10 Inalador de nicotina PT1061901E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002231968A CA2231968A1 (en) 1998-03-11 1998-03-11 Method of producing a nicotine medicament

Publications (1)

Publication Number Publication Date
PT1061901E true PT1061901E (pt) 2005-03-31

Family

ID=4162213

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99939159T PT1061901E (pt) 1998-03-11 1999-03-10 Inalador de nicotina

Country Status (14)

Country Link
US (3) US20010026788A1 (pt)
EP (1) EP1061901B1 (pt)
JP (1) JP2002506017A (pt)
KR (1) KR100598138B1 (pt)
CN (1) CN1183900C (pt)
AT (1) ATE281828T1 (pt)
AU (1) AU759039B2 (pt)
BR (1) BR9908680A (pt)
CA (1) CA2231968A1 (pt)
DE (1) DE69921785T2 (pt)
ES (1) ES2234282T3 (pt)
HK (1) HK1036940A1 (pt)
PT (1) PT1061901E (pt)
WO (1) WO1999045902A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6799576B2 (en) 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
US8256433B2 (en) 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
ES2292837T3 (es) * 2001-12-10 2008-03-16 Joseph Robert Knight Procedimiento para preparacion de una bebida tratada con una sustancia que contiene nicotina.
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
US20050150489A1 (en) * 2004-01-12 2005-07-14 Steve Dunfield Dispensing medicaments based on rates of medicament action
CN2719043Y (zh) 2004-04-14 2005-08-24 韩力 雾化电子烟
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US7726320B2 (en) 2006-10-18 2010-06-01 R. J. Reynolds Tobacco Company Tobacco-containing smoking article
US8757147B2 (en) 2010-05-15 2014-06-24 Minusa Holdings Llc Personal vaporizing inhaler with internal light source
US11344683B2 (en) 2010-05-15 2022-05-31 Rai Strategic Holdings, Inc. Vaporizer related systems, methods, and apparatus
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US9078473B2 (en) 2011-08-09 2015-07-14 R.J. Reynolds Tobacco Company Smoking articles and use thereof for yielding inhalation materials
JP5981123B2 (ja) * 2011-10-11 2016-08-31 サンサ コーポレーション （バルバドス） インク ニコチン薬の製造法およびその方法により製造される医薬
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
KR102665932B1 (ko) * 2013-12-05 2024-05-13 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 액제 및 그 방법
US9839238B2 (en) 2014-02-28 2017-12-12 Rai Strategic Holdings, Inc. Control body for an electronic smoking article
US20150283070A1 (en) * 2014-04-08 2015-10-08 Sansa Corporation (Barbados) Inc. Nicotine Formulations and Methods of Making the Same
KR102428028B1 (ko) 2014-04-28 2022-08-03 필립모리스 프로덕츠 에스.에이. 향미를 가진 니코틴 분말 흡입기
JP6712231B2 (ja) 2014-04-28 2020-06-17 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム ニコチン粉末吸入器
US9968125B2 (en) 2015-01-09 2018-05-15 Philip Morris Products S.A. Nicotine—diketopiperazine microparticle formulations and methods of making the same
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US10034494B2 (en) 2015-09-15 2018-07-31 Rai Strategic Holdings, Inc. Reservoir for aerosol delivery devices
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US20170071248A1 (en) * 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
US11224594B2 (en) * 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
EP3478265A1 (en) 2016-06-30 2019-05-08 Philip Morris Products S.a.s. Nicotine particles
RU2021132299A (ru) * 2016-06-30 2021-12-10 Филип Моррис Продактс С.А. Никотиносодержащие частицы и композиции
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
AU2019279884A1 (en) 2018-05-29 2020-12-10 Morningside Venture Investments Limited Drug delivery methods and systems
EP3574902A1 (en) * 2018-06-01 2019-12-04 Yatzz Limited Nicotine formulation and mode of delivery
CN112220756B (zh) * 2020-10-16 2023-06-13 重庆市义力医药科技有限公司 一种尼古丁颗粒组合物及其制备方法
WO2023187393A1 (en) 2022-03-31 2023-10-05 Hovione Scientia Limited Inhalation composite and carrier based formulation combination
CN117256920A (zh) * 2023-09-27 2023-12-22 东莞市吉纯生物技术有限公司 一种固体雾化物及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4635651A (en) * 1980-08-29 1987-01-13 Jacobs Allen W Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4655231A (en) * 1984-01-09 1987-04-07 Advanced Tobacco Products, Inc. Snuff and preparation thereof
US4655229A (en) * 1984-01-30 1987-04-07 R. J. Reynolds Tobacco Company Flavor delivery system
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking
NO168921C (no) * 1989-07-31 1992-04-22 Svein Knudsen Roekfri sigaretterstatning til bruk ved roekavvenning ellertil bruk i roekfrie miljoeer
US5512306A (en) * 1992-06-19 1996-04-30 Pharmica Ab Smoking substitute
US5035252A (en) * 1990-12-14 1991-07-30 Mondre Steven J Nicotine-containing dental floss
GB9200047D0 (en) * 1992-01-03 1992-02-26 Univ Alberta Nicotine-containing nasal spray
AU5171293A (en) * 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
US5441060A (en) * 1993-02-08 1995-08-15 Duke University Dry powder delivery system
US5376449A (en) * 1993-07-09 1994-12-27 Martin Marietta Energy Systems, Inc. Silica powders for powder evacuated thermal insulating panel and method
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
CA2146954C (en) * 1995-04-12 2008-06-17 Arthur Slutsky Breath activated nicotine inhalers
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
SE9502800D0 (sv) * 1995-08-10 1995-08-10 Astra Ab Disposable inhaler
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
GB9606677D0 (en) * 1996-03-29 1996-06-05 Glaxo Wellcome Inc Process and device
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6565947B2 (en) * 2000-01-11 2003-05-20 Nsk Ltd. Retaining piece structure

Also Published As

Publication number Publication date
AU759039B2 (en) 2003-04-03
ES2234282T3 (es) 2005-06-16
DE69921785T2 (de) 2005-12-22
CN1298294A (zh) 2001-06-06
WO1999045902A1 (en) 1999-09-16
US20070292519A1 (en) 2007-12-20
US20030103908A1 (en) 2003-06-05
US20010026788A1 (en) 2001-10-04
EP1061901A1 (en) 2000-12-27
CA2231968A1 (en) 1999-09-11
BR9908680A (pt) 2001-11-20
DE69921785D1 (de) 2004-12-16
AU3243599A (en) 1999-09-27
EP1061901B1 (en) 2004-11-10
CN1183900C (zh) 2005-01-12
KR100598138B1 (ko) 2006-07-10
ATE281828T1 (de) 2004-11-15
JP2002506017A (ja) 2002-02-26
HK1036940A1 (en) 2002-01-25
KR20010034594A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
PT1061901E (pt) Inalador de nicotina
JP3830158B2 (ja) 禁煙補助組成物
CA2146954A1 (en) Breath activated nicotine inhalers
IS1768B (is) Lyfjablanda til innöndunar sem inniheldur insúlín
EE04628B1 (et) Perforeeritud mikrostruktuure sisaldav pulber ja meetod perforeeritud mikrostruktuure sisaldava mikroosakeste kompositsiooni ning pulbri valmistamiseks
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
FI951465A0 (fi) Parathormonin aktiivisten fragmenttien annostelu keuhkojen kautta
HUP0102892A2 (hu) Erősen tömörített szilárd gyógyszerkészletet tartalmazó hatóanyag-leadó rendszer, eljárás az előállítására és alkalmazására
NZ507151A (en) Pulmonary and nasal delivery of raloxifene
DE69810355D1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma
MX9700034A (es) Formulacion para la aplicacion por inhalacion.
JPH072654A (ja) 吸入によるタウリン投与装置
BR9913722A (pt) Partìculas para fornecimento de um agente ativo aos alvéolos de um paciente humano, e método para a preparação das mesmas, método para fornecimento de um agente ativo aos pulmões de um paciente humano, e método para aumentar a quantidade de um agente ativo inalado depositado no pulmão profundo
CA2240717A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
JP2001527442A (ja) ハロセラピーの投与方法
EE04038B1 (et) Inhaleeritav formoterooli sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml, meetod selle valmistamiseks ning kasutamine
CA2265198A1 (en) Method of producing a nicotine medicament and a medicament made by the method
US20120018526A1 (en) Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution
EE03950B1 (et) Inhaleeritav terbutaliinsulfaati sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml, meetod selle valmistamiseks ja kasutamine
ATE251447T1 (de) Pharmazeutische zubereitungen zur inhalation eines opioids
EP0741588B1 (en) Method to produce an aerosol
Burch et al. Plasma Nicotine Levels after Inhalation of Aerosolized Nicotine1-3
CN105078930A (zh) 一种烟雾药剂及其制备方法
CN1140062A (zh) 戒烟穴贴膏
JP2002161030A (ja) 異なる粒径をもった混合粉体の吸入方法